Hernia Repair Devices Market Revenue to Cross USD 8.62 billion by 2031 – Exclusive Report by Transparency Market Research
29 sept. 2023 06h36 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The hernia repair devices market was valued at US$ 5.5 billion in 2020. The hernia repair...
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
05 févr. 2019 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will...
Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019
20 déc. 2018 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will...
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
17 déc. 2018 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
06 déc. 2018 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court
04 déc. 2018 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
Arch Therapeutics Announces Submission of CE Mark File for AC5™ Topical Hemostat in Europe
28 nov. 2018 07h50 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Surgical Staplers Market to Reach $5.4 Billion by 2023: P&S Market Research
17 oct. 2017 02h30 HE
|
P&S Market Research
NEW YORK, Oct. 17, 2017 (GLOBE NEWSWIRE) -- According to new market research report titled “Surgical Staplers Market by Product (Manual Surgical Stapler, Powered Surgical Stapler), by Type...
Megadyne(R) Adds ENDOPATH(R) Electrosurgery Probe Plus II to Electrosurgical Portfolio
12 mars 2014 13h02 HE
|
Megadyne, Inc.
DRAPER, UT--(Marketwired - Mar 12, 2014) - Megadyne Medical Products, a leading developer, manufacturer and supplier of electrosurgical products, today announced the expansion of its commercial...